
There is a need for new, clinically relevant interpretation zzso for zzso and zzso resistance for zzso zzso zzso at the current approved dosage zzso zzso twice a day zzso Clinical zzso levels, which correlate baseline measures of resistance with zzso zzso responses in large zzso or clinical trials, are the ideal reference for developing such zzso zzso levels previously developed for zzso zzso may no longer apply, as the plasma drug levels with zzso are significantly higher and may be able partially to overcome zzso zzso zzso Clinical zzso levels for zzso assessed in several cohort studies and clinical trials, also suggest that multiple zzso zzso are required for complete loss of zzso zzso For zzso analysis of resistance, zzso zzso levels zzso higher than the zzso zzso have best distinguished zzso from zzso in cohort zzso Using zzso zzso a zzso upper zzso level was determined from analysis of large cohort zzso These zzso and zzso zzso need to be validated in larger prospective zzso 

